MedTrace Logo

6-month Efficacy and Safety of Synolis VA 80/160 in Hip Osteoarthritis

NCT05829733 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 70

Last updated 2025-12-12

No results posted yet for this study

Summary

Multicenter, independent study of Synolis VA 80/160 over a period of 6 months

Conditions

  • Osteoarthritis, Hip

Interventions

DEVICE

SYNOLIS VA 80/160

SYNOLIS VA 80/160 (hyaluronic acid 80 mg, sorbitol 160 mg)

Sponsors & Collaborators

  • Aptissen SA

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-05-27
Primary Completion
2027-04-30
Completion
2027-04-30

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05829733 on ClinicalTrials.gov